Conveners
Session 5 - Nuclear fuel cycles, Research Reactors and present NPP (including Gen IV and Th reactors)
- Horst Geckeis (Karlsruhe Institute of Technology, Germany)
- Paolo Giovanni Saracco (INFN Genova, Italy)
Luciano Cinotti
(M.E.Rivus s.r.l, Italy)
18/09/2012, 14:55
Nuclear fuel cycles, present Gen III+ NPPs, Gen IV and Th based reactors
Invited Lecture
The path to develop advanced nuclear reactors that are superior to current systems is described in the 2002 Roadmap Report entitled “A Technology Roadmap for Generation IV Nuclear Energy Systems” which was prepared by the Generation IV International Forum (GIF) in 2002. This roadmap defined challenging technology goals for advanced reactor systems in four major areas:
• Sustainability,
•...
Dr
Wei-Qun Shi
(Institute of High Energy Physics,Chinese Academy of Sciences, China)
18/09/2012, 15:30
Nuclear fuel cycles, present Gen III+ NPPs, Gen IV and Th based reactors
Invited Lecture
Nuclear energy chemistry is one of the frontier areas of chemistry with high impact on national security, energy supply, scientific advances, social and economic development. Nuclear energy chemistry in China is now experiencing a renaissance, which is being strongly motivated by China’s huge demand for nuclear energy. In this presentation, the progress in nuclear energy chemistry of China is...
Dr
Francesco TROIANI
(ENEA/NUCLECO SpA), Dr
Giacomo GRASSO
(ENEA)
18/09/2012, 15:50
Nuclear fuel cycles, present Gen III+ NPPs, Gen IV and Th based reactors
Invited Lecture
The growing awareness of the urgent need to reduce emissions of greenhouse gases and to increase the security of energy supply are changing significantly the energy scenarios of the world and low-carbon energy technologies in the next future will play a crucial role. To this end, although severe accidents occurred over the years, many countries are still considering nuclear energy as an...
Dr
Vladimir A. Pavshuk
(Russian Research Center “Kurchatov Institute”, Russia)
18/09/2012, 16:10
Nuclear fuel cycles, present Gen III+ NPPs, Gen IV and Th based reactors
Invited Lecture
Molybdenum-99 is the most important and widely used medical radionuclide which production in required quantities is possible only by fission products of Uraniun-235. In clinical practice the share of Mo-99 usage reaches approximately 80% of the total amount of radioisotope diagnostic procedures in the world. Strontium-89 is used for oncology and anesthesia and is capable of replacing...
